← All stocks

NATURES SUNSHINE PRODUCTS INC

NATR Net selling
CIK 0000275053 #3746 in the set updated 17 Sep 2026
Bought (120 mo)
$5.60M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$42.04M
$0.00 on a plan · $452.24K straight out of an exercise
Sold at will
$41.59M
69 of 72 sales
Net
−$36.44M
−$35.99M against sales at will

By person

43 insiders · 198 transactions

There is no salary here to measure against. NATURES SUNSHINE PRODUCTS INC's chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. entity
10% owner
$32.89M (8)
−$32.89M
2,893,732
16.45%
$42.51M
−49.1%
WYNNEFIELD PARTNERS SMALL CAP VALUE LP entity
10% owner
$2.96M (109)
+$2.96M
4,550,315
25.86%
$66.84M
+7.3%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. entity
10% owner
$2.63M (17)
$4.75M (1)
−$2.12M
3,443,890
19.57%
$50.59M
−8.9%
Norman Daniel C
EVP & President, Asia
$1.39M (13)
−$1.39M
47,276
0.2687%
$694.48K
−23.5%
Yates Bryant J
EVP & President, Europe
$1.32M (13)
−$1.32M
77,446
0.4401%
$1.14M
+3.3%
Brower Nathan G
EVP, General Counsel
$741.68K (7)
−$741.68K
43,438
0.2469%
$638.10K
+87.7%
HUGHES KRISTINE F
Director
$623.91K (25)
−$623.91K
641,646
3.65%
$9.43M
−7.8%
Lanoy Jonathan David
SVP, Chief Accounting Officer
$283.60K (3)
−$283.60K
55,602
0.3160%
$816.79K
+156.0%
Herbert Kevin R.
EVP & President, North America
$41.36K (2)
−$41.36K
46,890
0.2665%
$688.81K
Moorehead Terrence
Chief Executive Officer
543,292
3.09%
$7.98M
MESDAG WILLEM
10% owner
524,997
2.98%
$7.71M
−82.1%
PROBERT GREGORY
CEO & Chairman of the Board
201,305
1.14%
$2.96M
+18.8%
BATY JOSEPH W
EVP & Chief Financial Officer
173,702
0.9872%
$2.55M
Romanzi Kenneth G.
Chief Executive Officer
143,999
0.8184%
$2.12M
Jones Leslie Shane
EVP & Chief Financial Officer
104,658
0.5948%
$1.54M
+54.3%
Perkins Ruth Ann
EVP, Chief Financial Officer
75,433
0.4287%
$1.11M
Gonzalez Martin A.
EVP, Global Supply Chain
69,640
0.3958%
$1.02M
Comstock Tracee
VP, Human Resources
64,449
0.3663%
$946.76K
+48.4%
Mercer Robert B
Director
60,688
0.3449%
$891.51K
+176.6%
NOACK PAUL
President, China & New Markets
60,278
0.3426%
$885.48K
+10.6%
Straus Robert D
Director
56,514
0.3212%
$830.19K
Teets John Christopher
Director
55,315
0.3144%
$812.58K
+912.4%
Silcock Edward
EVP & President, North America
51,486
0.2926%
$756.33K
+43.1%
SPRINGER MARY BETH
Director
48,352
0.2748%
$710.29K
+259.8%
Watkins Jeffrey D
Director
44,915
0.2553%
$659.80K
+118.7%
Wissmiller Heidi
Director
41,667
0.2368%
$612.09K
MOSS RICHARD D
Director
38,629
0.2195%
$567.46K
Armstrong Susan M
EVP & Chief Operations Officer
37,651
0.2140%
$553.09K
+87.0%
Yang Rong
Director
34,749
0.1975%
$510.46K
Kopf Curtis
Director
34,427
0.1957%
$505.73K
Roering Tess
Director
34,427
0.1957%
$505.73K
Fuller Kevin Gregory
Global Chief Marketing Officer
31,548
0.1793%
$463.44K
DOWDEN ALBERT R
Director
27,221
0.1547%
$399.88K
+26.4%
Strulson Richard
EVP/Gen. Counsel/CCO
27,140
0.1542%
$398.69K
+5.1%
Crockett Sarah
Global Chief Marketing Officer
26,873
0.1527%
$394.76K
Fritz Erich A
EVP, Global Supply Chain
20,889
0.1187%
$306.86K
Jia Hongfei
Director
18,035
0.1025%
$264.93K
Fasching Steven J.
Director
15,369
0.0873%
$225.77K
Steinfort Rebecca Lee
Director
15,022
0.0854%
$220.67K
+60.8%
May Katie
Director
14,266
0.0811%
$209.57K
Zou Lily
Director
12,394
0.0704%
$182.07K
Wu Shirley
Director
9,149
0.0520%
$134.40K
Hassan Tariq
Director
3,119
0.0177%
$45.82K
Insider
Date
Role
Action
Shares
Price
Amount
Yates Bryant J
29 Aug 2023
EVP & President, Europe
Sold after exercise
15,000
$16.77
$251.55K
Norman Daniel C
28 Aug 2023
EVP & President, Asia
Sold after exercise
12,036
$16.40
$197.39K
Norman Daniel C
25 Aug 2023
EVP & President, Asia
Sold after exercise
200
$16.50
$3.30K

What was left out

Form 4 filings counted 440
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 38
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 69
Transactions with no price 0
Shares from compensation/vesting 5,701,119
Sales filed before the plan box existed 27
History held since 2 Nov 2016